Observational studyJournal of thrombosis and thrombolysis2019

Safety, efficacy, and cost of four-factor prothrombin complex concentrate (4F-PCC) in patients with factor Xa inhibitor-related bleeding: a retrospective study.

Melanie N Smith et al.PubMed ↗Publisher ↗

No numbers read from the abstract.